Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders.

Literature DB >> 20065624

SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders.

A Godano¹, M Maggi, E Jannini, M C Meriggiola, E Ghigo, O Todarello, A Lenzi, C Manieri.

Abstract

Mesh：

Substances：

Year: 2009 PMID： 20065624 DOI： 10.1007/BF03345758

Source DB: PubMed Journal: J Endocrinol Invest ISSN： 0391-4097 Impact factor: 4.256

× No keyword cloud information.

13 in total

Review 1. Endocrine intervention for transsexuals.

Authors: Andy Levy; Anna Crown; Russell Reid
Journal: Clin Endocrinol (Oxf) Date: 2003-10 Impact factor: 3.478

2. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.

Authors: R Dittrich; H Binder; S Cupisti; I Hoffmann; M W Beckmann; A Mueller
Journal: Exp Clin Endocrinol Diabetes Date: 2005-12 Impact factor: 2.949

3. The treatment of adolescent transsexuals: changing insights.

Authors: Peggy T Cohen-Kettenis; Henriette A Delemarre-van de Waal; Louis J G Gooren
Journal: J Sex Med Date: 2008-06-28 Impact factor: 3.802

Review 4. Endocrine therapy of transsexualism and potential complications of long-term treatment.

Authors: W Futterweit
Journal: Arch Sex Behav Date: 1998-04

5. Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals.

Authors: Andreas Mueller; Franklin Kiesewetter; Helge Binder; Matthias W Beckmann; Ralf Dittrich
Journal: J Clin Endocrinol Metab Date: 2007-06-19 Impact factor: 5.958

6. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients.

Authors: Michael Zitzmann; Marion Depenbusch; Jörg Gromoll; Eberhard Nieschlag
Journal: J Clin Endocrinol Metab Date: 2004-12 Impact factor: 5.958

Review 5. Estradiol Therapy in the Perioperative Period: Implications for Transgender People Undergoing Feminizing Hormone Therapy.

Authors: Brendan J Nolan; Ada S Cheung
Journal: Yale J Biol Med Date: 2020-09-30

5 in total

SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders.

Review 1. Endocrine intervention for transsexuals.

2. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.

3. The treatment of adolescent transsexuals: changing insights.

Review 4. Endocrine therapy of transsexualism and potential complications of long-term treatment.

5. Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals.

6. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients.

Review 7. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.

Review 8. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.

Review 9. The role of the CAG repeat androgen receptor polymorphism in andrology.

10. Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals.

1. Quality of life and hormones after sex reassignment surgery.

2. Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG.

Review 3. Cross-sex hormone therapy for gender dysphoria.

4. Use of Hormones Among Trans Women in the West Coast of Peninsular Malaysia: A Mixed Methods Study.

Review 5. Estradiol Therapy in the Perioperative Period: Implications for Transgender People Undergoing Feminizing Hormone Therapy.